Subacute cutaneous lupus erythematosus in childhood

Pediatric Dermatology

Volumn 20, Issue 1, 2003, Pages 31-34

  Amato, Lauretta ^a   Coronella, Giordana ^a   Berti, Samantha ^a   Moretti, Silvia ^a,b   Fabbri, Paolo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Clinica Dermatologica II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CORTICOSTEROID; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN M; METHYLPREDNISOLONE; RHEUMATOID FACTOR; RO ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CASE REPORT; CHILDHOOD; CLINICAL FEATURE; COMPLEMENT DEPOSITION; DERMOEPIDERMAL JUNCTION; DISEASE COURSE; ERYTHEMA; FEMALE; HISTOPATHOLOGY; HLA TYPING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERKERATOSIS; IMMUNOPATHOLOGY; LUPUS ERYTHEMATOSUS CELL TEST; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; SCHOOL CHILD; SKIN BIOPSY; SKIN LUPUS ERYTHEMATOSUS; SUN EXPOSURE; TREATMENT OUTCOME; ACUTE DISEASE; CHILD; DRUG COMBINATION; FOLLOW UP; HOSPITALIZATION; IMMUNOHISTOCHEMISTRY; NEEDLE BIOPSY; PATHOLOGY; TOPICAL DRUG ADMINISTRATION;

ACUTE DISEASE; ADMINISTRATION, TOPICAL; AUTOANTIBODIES; BIOPSY, NEEDLE; CHILD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYCHLOROQUINE; IMMUNOHISTOCHEMISTRY; LUPUS ERYTHEMATOSUS, CUTANEOUS; METHYLPREDNISOLONE; SEVERITY OF ILLNESS INDEX;

EID: 0038545404     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1470.2003.03007.x     Document Type: Article

References (12)

1. Sontheimer RD, Thomas JR, Gilliam JN. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 1979;115:1409-1415.
2. Sontheimer RD. Subacute cutaneous lupus erythematosus: a decade's perspective. Med Clin N Am 1989;73:1073-1090.
3. Parodi A, Caproni M, Cardinali C, et al. Clinical, histological and immunopathological features of 58 patients with subacute cutaneous lupus erythematosus. Dermatology 2000;200:6-10.
4. Chlebus E, Wolska H, Blaszezyk M, Jablonska S. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications. J Am Acad Dermatol 1998;38:405-412.
5. Callen JP, Klein J. Subacute cutaneous lupus erythematosus: clinical, serologic, immunogenetic, and therapeutic considerations in seventy-two patients. Arthritis Rheum 1988;31:1007-1013.
6. Hood AF, Farmer ER. Histopathology of cutaneous lupus erythematosus. Clin Dermatol 1985;3:36-48.
7. Valeski JE, Kumar V, Forman AB, Beutner EH, Chorzelski TP. A characteristic cutaneous direct immunofluorescent pattern associated with Ro (SS-A) antibodies in subacute cutaneous lupus erythematosus. J Am Acad Dermatol 1992;27:194-198.
8. Nieboer C, Tak-Diamand Z, Vanleeuwen-Wallau HE. Dust-like particles: a specific direct immunofluorescence pattern in subacute cutaneous lupus erythematosus. Br J Dermatol 1988;118:725-734.
9. Lee LA, Weston WL. Lupus erythematosus in childhood. Dermatol Clin 1986;4:151-160.
10. Siamopoulou-Mavridou A, Stefanou D, Drosos AA. Subacute cutaneous lupus erythematosus in childhood. Clin Rheumatol 1989;8:533-537.
11. Buckley D, Barnes L. Childhood subacute cutaneous lupus erythematosus associated with homozygous complement 2 deficiency. Pediatr Dermatol 1995;12: 327-330.
12. Sontheimer RD, Maddison PJ, Reichlin M, Jordon RE, Stastny P, Gilliam JN. Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med 1982;97: 664-671.